Avraham Lorber
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Avraham Lorber has a total of 66 co-authors. Here are the top co-authors by number of shared publications:
- Sergey Yalonetsky
Department of Cardiology, Rambam Health Care Campus, HaAliya HaShniya 8 Street, Haifa, 3108601
7 shared publications Yitzhack Schwartz
6 shared publicationsAsaad Khoury
Department of Pediatric Cardiology, Rambam Health Care Campus, Technion-Institute of Technology, Haifa, Israel
5 shared publicationsRoie Tal
Department of Pediatrics, Galilee Medical Center, Naharia, Israel
5 shared publicationsYulia Braver
Unit of Pediatric Cardiology, Meyer Children's Hospital, Rambam Medical Center, Technion-Israel Institute of Technology, Haifa, 31096, Israel
5 shared publications- Miri Cohen
Braude College of Engineering
4 shared publications
Latest Publications
- Open Access
- 7 May 2024
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 13 (9) , e031760
Arrhythmia Burden Among Adult Patients With Congenital Heart Disease: A Population‐Based Study
Background: A significant percentage of patients with congenital heart disease surviving into adulthood will develop arrhythmias. These arrhythmias are associated with an increased risk of adverse events and death. We aimed to assess arrhythmia prevalence, risk factors, and associated health care usage in a large national cohort of patients with adult congenital heart disease. Methods and Results: Adults with a documented diagnosis of congenital heart disease, insured by Clalit and Maccabi health services between January 2007 and December 2011, were included. We assessed the associations between arrhythmia and subsequent hospitalization rates and death with mixed negative binomial and Cox proportional hazard models, respectively. Among 11 653 patients with adult congenital heart disease (median age, 47 years [interquartile range, 31–62]), 8.7% had a tachyarrhythmia at baseline, 1.5% had a conduction disturbance, and 0.5% had both. Among those without a baseline arrhythmia, 9.2% developed tachyarrhythmias, 0.9% developed a conduction disturbance, and 0.3% developed both during the study period. Compared with no arrhythmia (reference group), arrhythmia in the previous 6 months was associated with a higher multivariable adjusted hospitalization rate, 1.33‐fold higher than the rate of the reference group (95% CI, 1.00–1.76) for ventricular arrhythmia, 1.27‐fold higher (95% CI, 1.17–1.38) for atrial arrhythmias, and 1.33‐fold higher (95% CI, 1.04–1.71) for atrioventricular block. Atrial tachyarrhythmias were associated with an adjusted mortality hazard ratio (HR) of 1.65 (95% CI, 1.44–2.94), and ventricular tachyarrhythmias with a >2‐fold increase in mortality risk (HR, 2.06 [95% CI, 1.44–2.94]). Conclusions: Arrhythmias are significant comorbidities in the adult congenital heart disease population and have a significant impact on health care usage and survival.
- 7 May 2024
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 13 (9) , e031760
Open AccessArrhythmia Burden Among Adult Patients With Congenital Heart Disease: A Population‐Based Study
Background: A significant percentage of patients with congenital heart disease surviving into adulthood will develop arrhythmias. These arrhythmias are associated with an increased risk of adverse events and death. We aimed to assess arrhythmia prevalence, risk factors, and associated health care usage in a large national cohort of patients with adult congenital heart disease. Methods and Results: Adults with a documented diagnosis of congenital heart disease, insured by Clalit and Maccabi health services between January 2007 and December 2011, were included. We assessed the associations between arrhythmia and subsequent hospitalization rates and death with mixed negative binomial and Cox proportional hazard models, respectively. Among 11 653 patients with adult congenital heart disease (median age, 47 years [interquartile range, 31–62]), 8.7% had a tachyarrhythmia at baseline, 1.5% had a conduction disturbance, and 0.5% had both. Among those without a baseline arrhythmia, 9.2% developed tachyarrhythmias, 0.9% developed a conduction disturbance, and 0.3% developed both during the study period. Compared with no arrhythmia (reference group), arrhythmia in the previous 6 months was associated with a higher multivariable adjusted hospitalization rate, 1.33‐fold higher than the rate of the reference group (95% CI, 1.00–1.76) for ventricular arrhythmia, 1.27‐fold higher (95% CI, 1.17–1.38) for atrial arrhythmias, and 1.33‐fold higher (95% CI, 1.04–1.71) for atrioventricular block. Atrial tachyarrhythmias were associated with an adjusted mortality hazard ratio (HR) of 1.65 (95% CI, 1.44–2.94), and ventricular tachyarrhythmias with a >2‐fold increase in mortality risk (HR, 2.06 [95% CI, 1.44–2.94]). Conclusions: Arrhythmias are significant comorbidities in the adult congenital heart disease population and have a significant impact on health care usage and survival.
- 1 June 2021
- Published by Elsevier in Progress in Pediatric Cardiology
- Vol. 61, 101338
When answers cannot be found in the textbook: Making ethical decisions regarding children with profound disabilities
- 1 June 2021
- Published by Elsevier in Progress in Pediatric Cardiology
- Vol. 61, 101338
When answers cannot be found in the textbook: Making ethical decisions regarding children with profound disabilities
- 1 January 2021
- Published by Elsevier in Geriatric Nursing
- Vol. 42 (1) , 173-180
Providing regular grandchild care: Grandparents’ psychological and physical health
- 1 January 2021
- Published by Elsevier in Geriatric Nursing
- Vol. 42 (1) , 173-180
Providing regular grandchild care: Grandparents’ psychological and physical health
- 27 February 2017
- Published by Science International Corporation in Journal of Structural Heart Disease
- Vol. 3 (1) , 15-27
Challenges in Atrial Septal Defect Occlusion
- 27 February 2017
- Published by Science International Corporation in Journal of Structural Heart Disease
- Vol. 3 (1) , 15-27
Challenges in Atrial Septal Defect Occlusion
- 6 March 2016
- Published by Wiley in Acta Paediatrica
- Vol. 105 (6) , 600-604
Approach to haemangiomatosis causing congestive heart failure
Haemangiomas represent the most common tumour of infancy. Although most cases are cutaneous benign lesions, multiple skin haemangiomas are associated with visceral involvement, especially of the liver. Hepatic haemangiomatosis may be complicated by high-output cardiac failure due to high-flow arteriovenous connections within the lesions. Different therapeutic strategies for treating haemangiomatosis causing heart failure include medical, surgical and interventional modalities. This study aimed to review the treatment options, discuss their benefits and flaws and propose a practical therapeutic approach for this medical situation. Our approach incorporates heart failure medications, dietary support and propranolol as first-line treatment, while corticosteroids, vincristine, percutaneous intervention and surgery are reserved for refractory cases.
- 6 March 2016
- Published by Wiley in Acta Paediatrica
- Vol. 105 (6) , 600-604
Approach to haemangiomatosis causing congestive heart failure
Haemangiomas represent the most common tumour of infancy. Although most cases are cutaneous benign lesions, multiple skin haemangiomas are associated with visceral involvement, especially of the liver. Hepatic haemangiomatosis may be complicated by high-output cardiac failure due to high-flow arteriovenous connections within the lesions. Different therapeutic strategies for treating haemangiomatosis causing heart failure include medical, surgical and interventional modalities. This study aimed to review the treatment options, discuss their benefits and flaws and propose a practical therapeutic approach for this medical situation. Our approach incorporates heart failure medications, dietary support and propranolol as first-line treatment, while corticosteroids, vincristine, percutaneous intervention and surgery are reserved for refractory cases.
- 1 March 2014
- Published by Elsevier in International Journal of Cardiology
- Vol. 172 (1) , e175-e176
Trisomy 13 (Patau syndrome) with tetralogy of Fallot — To treat or not to treat?
- 1 March 2014
- Published by Elsevier in International Journal of Cardiology
- Vol. 172 (1) , e175-e176
Trisomy 13 (Patau syndrome) with tetralogy of Fallot — To treat or not to treat?
- 25 February 2013
- Published by Wiley in Acta Paediatrica
- Vol. 102 (5) , e232-e238
Congestive heart failure with diffuse neonatal hemangiomatosis – case report and literature review
Background: Vascular hemangiomas are considered to be a common finding among neonates and infants. The presence of five or more cutaneous hemangiomas may carry a higher incidence of multiple organ involvementMaterials & Methods: An eleven week old female infant with high cardiac output heart failure and multiple cutaneous hemangiomas was referred to our clinic. Soon after birth she failed to gain weight and developed breathlessness. There was partial response to Captopril and Frusemide therapy, with development of a progressive cough. Echocardiogram and liver and brain ultrasound scans revealed heart chamber enlargement, multiple liver hemangiomas and an isolated cerebellar arterio‐venous malformation (AVM). Supportive treatment for congestive heart failure combined with propranolol therapy resulted in rapid clinical response and recovery.Discussion: The diagnosis of Diffuse Neonatal Hemangiomatosis in infants with failure to thrive and symptoms of heart failure raises the possibility of internal organ involvement. Augmentation of propranolol in such cases may cause regression of Hemangiomatosis with patient clinical improvement.Conclusion: We report our experience with a single patient of Hemangiomatosis induced heart failure which responded to propranolol combined with medication to control heart failure and failure to thrive prevention. This treatment should be further evaluated with special attention to potential adverse effects, tolerance and compliance
- 25 February 2013
- Published by Wiley in Acta Paediatrica
- Vol. 102 (5) , e232-e238
Congestive heart failure with diffuse neonatal hemangiomatosis – case report and literature review
Background: Vascular hemangiomas are considered to be a common finding among neonates and infants. The presence of five or more cutaneous hemangiomas may carry a higher incidence of multiple organ involvementMaterials & Methods: An eleven week old female infant with high cardiac output heart failure and multiple cutaneous hemangiomas was referred to our clinic. Soon after birth she failed to gain weight and developed breathlessness. There was partial response to Captopril and Frusemide therapy, with development of a progressive cough. Echocardiogram and liver and brain ultrasound scans revealed heart chamber enlargement, multiple liver hemangiomas and an isolated cerebellar arterio‐venous malformation (AVM). Supportive treatment for congestive heart failure combined with propranolol therapy resulted in rapid clinical response and recovery.Discussion: The diagnosis of Diffuse Neonatal Hemangiomatosis in infants with failure to thrive and symptoms of heart failure raises the possibility of internal organ involvement. Augmentation of propranolol in such cases may cause regression of Hemangiomatosis with patient clinical improvement.Conclusion: We report our experience with a single patient of Hemangiomatosis induced heart failure which responded to propranolol combined with medication to control heart failure and failure to thrive prevention. This treatment should be further evaluated with special attention to potential adverse effects, tolerance and compliance
- Open Access
- 27 November 2012
- Published by Springer Nature in Cardiology and Therapy
- Vol. 2 (1) , 97-102
Fenestrated Atrial Septal Defect Percutaneously Occluded by a Single Device: Procedural and Financial Considerations
A 45-year-old patient presented with a cerebrovascular attack and was subsequently found to have a multi-fenestrated atrial septal defect. Various therapeutic options for percutaneous transcatheter closure with their respective benefits and flaws are discussed, as well as procedural and financial considerations. The decision making process leading to a successful result using a single occlusive device is presented, alongside a review of the literature.
- 27 November 2012
- Published by Springer Nature in Cardiology and Therapy
- Vol. 2 (1) , 97-102
Open AccessFenestrated Atrial Septal Defect Percutaneously Occluded by a Single Device: Procedural and Financial Considerations
A 45-year-old patient presented with a cerebrovascular attack and was subsequently found to have a multi-fenestrated atrial septal defect. Various therapeutic options for percutaneous transcatheter closure with their respective benefits and flaws are discussed, as well as procedural and financial considerations. The decision making process leading to a successful result using a single occlusive device is presented, alongside a review of the literature.
- 29 July 2011
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 79 (4) , 678-680
Taming the “cobra”: An approach to “Cobra‐Like” formation seen in the occlutech atrial septal defect and patent foramen ovale occluders
Percutaneous closure of secundum atrial septal defect and patent foramen ovale has gained widespread use in recent years. We present a small series of four cases in which a “cobra‐like” formation occurred in an Occlutech Figulla device during the deployment of the left disk, and propose a technique that may resolve this problem.
- 29 July 2011
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 79 (4) , 678-680
Taming the “cobra”: An approach to “Cobra‐Like” formation seen in the occlutech atrial septal defect and patent foramen ovale occluders
Percutaneous closure of secundum atrial septal defect and patent foramen ovale has gained widespread use in recent years. We present a small series of four cases in which a “cobra‐like” formation occurred in an Occlutech Figulla device during the deployment of the left disk, and propose a technique that may resolve this problem.
- 30 June 2011
- Published by Elsevier in Archives of Gerontology and Geriatrics
- Vol. 52 (3) , e152-e155
Comparison of psychological symptoms in post-cryptogenic cerebral-vascular accident (CVA) and/or transient ischemic attack (TIA) patients who have undergone foramen ovale closure, and in post-CVA patients
- 30 June 2011
- Published by Elsevier in Archives of Gerontology and Geriatrics
- Vol. 52 (3) , e152-e155
Comparison of psychological symptoms in post-cryptogenic cerebral-vascular accident (CVA) and/or transient ischemic attack (TIA) patients who have undergone foramen ovale closure, and in post-CVA patients